跳至主要内容
临床试验/NCT00846014
NCT00846014撤回不适用

Asthma Exacerbation and Helium-3 MRI

University of Massachusetts, Worcester1 个研究点 分布在 1 个国家开始时间: 2009年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
1
主要终点
Image and quantify variation in asthmatic lungs at 0, 6 months, and 12 months

研究概览

简要总结

The goal of this research is to use Helium-3 MRI to see the changes in airflow of the lungs at different times of an attack. These three stages are immediately after the attack, 1 month later and 4-6 months later.

详细描述

Asthma is a pulmonary disorder that affects millions of people each year. The exact method of exacerbation is still under some discussion. Currently there is no cure for the disorder but treatment is of a wide variety.

This study is meant to image the asthmatic lung at various time points post exacerbation. Since pulmonary imaging is currently limited to radiation techniques, this method will allow exacerbated images without the unnecessary exposure to radiation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Asthmatics

Experimental

All subjects will be asthmatics that have had an exacerbation (asthma attack) no more than 48 hours before the imaging session.

干预措施: Helium-3 (Drug)

结局指标

主要结局

Image and quantify variation in asthmatic lungs at 0, 6 months, and 12 months

时间窗: 1 year

次要结局

未报告次要终点

研究者

发起方
University of Massachusetts, Worcester
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mitchell Albert

Director of Advanced MRI Center, UMASS Medical Sch

University of Massachusetts, Worcester

研究点 (1)

Loading locations...

相似试验